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WHAT THIS PAPER ADDS
Although conservative management is the ﬁrst therapy of choice in patients with central venous catheter related
infected thrombosis, surgical treatment that removes the septic material can be regarded as a last resort in
critically ill patients with septic thrombophlebitis that is refractory to conservative management.
Objective/Background: The aim of this study was to evaluate the clinical features and outcomes of catheter
related central venous thrombosis and whether a surgical approach can be an effective treatment modality in
selected cases that are refractory to conservative management.
Methods: This was a retrospective review of the 46 consecutive patients who were suspected of having central
venous catheter related infected deep venous thrombosis and who met the eligibility criteria.
Results: Conservative management achieved clinical improvement in 26 (56.5%) patients and failed in 20
(43.5%), of whom surgical thrombectomy was performed in 13. The remaining seven patients died before surgery
could be performed or their clinical condition was too poor. Apart from one case of wound hematoma (7.7%),
post-operative complications that related to the surgical procedure were not observed. Patency of the involved
vein was re-established in 12 of the 13 (92.3%) surgically treated patients, and clinical improvement was achieved
in 11 (84.6%). In particular, the ﬁve patients whose blood cultures revealed Candida species exhibited prompt
defervescence after surgical thrombectomy.
Conclusion: Although conservative management is the ﬁrst therapy of choice in patients with central venous
catheter related infected thrombosis, surgical treatment that removes the septic material can be regarded as a
last resort in critically ill patients with septic thrombophlebitis that is refractory to conservative management.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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INTRODUCTION
Central venous catheters are now used widely in the care of
critically ill patients; they deliver total parenteral nutrition
and drug therapy, and facilitate hemodynamic monitoring.
However, these catheters can cause central venous throm-
bosis.1e9 Moreover, the long-term hospitalized critically ill
patients who receive central venous catheters have a higher
risk of malnutrition, which is associated with immunosup-
pression, which, in turn, is a risk factor for infection.6e11
However, the incidence of central venous catheter related
infected thrombosis (which affects the internal jugular or
subclavian veins and vena cavae) is small. Indeed, suppura-
tive deep venous thrombosis in critically ill patients is
sometimes detected only incidentally during diagnostic work
up. Conservative management consisting of removing the
catheter, antibiotic therapy, and anticoagulation therapy can
resolve this condition in the majority of patients. However,
occasionally it fails and serious complications, such as
persistent bacteremia, shock, and metastatic infection can
occur.3e9 If conservative management fails, the best treat-
ment for symptomatic catheter related thrombosis is unclear.
Although some authors believe that a surgical approach that
aims to remove the infected clots is a last treatment modality
for critically ill patients with septic thrombosis that is re-
fractory to conservative management, others consider
venous thrombectomy to be unnecessary.1e9
This study was designed to explore two aspects of cath-
eter related infected central venous thrombosis. First, the
clinical features and outcomes of catheter related central
venous thrombosis were assessed. Second, whether a sur-
gical approach can be an effective treatment modality in
selected cases that are refractory to conservative manage-
ment was also investigated.
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METHODS
This retrospective observational study was based on data
that were extracted from patient medical records. The study
protocol was approved by the hospital institutional review
board. The study population consisted of 50 consecutive
patients who were suspected of central venous catheter
related septic deep venous thrombosis and who received
conservative management at a tertiary care institution
(Asan Medical Center) between January 2009 and
December 2012 (Fig. 1). The inclusion criteria for the pre-
sent study were as follows: (1) temperature  38.4 C,
which persisted for > 2 days after the removal or change of
the central venous catheter and antibiotic therapy; (2) a
central venous catheter was in place prior to and up to the
onset of fever; (3) Duplex ultrasonography (DUS) or
computed tomographic (CT) scanning revealed the presence
of central venous catheter related thrombosis; and (4) there
were no other plausible causes of fever or sepsis. Clinical
improvement was deﬁned as the continuous abatement of
fever without any evidence of sepsis and negative culture
results despite discontinuation of antimicrobial therapy.
At the authors’ institution, conservative management is
the ﬁrst therapy of choice. When central venous catheter
related thrombosis is suspected to be the source of sepsis,
the line is either removed directly or changed over a
guidewire. A 3 inch segment of catheter just distal to the
hub is then sent for culture, and blood for blood culture is
obtained via the catheter. After appropriate blood and
catheter sample culture, empirical intravenous antimicro-
bial therapy and anticoagulation therapy are initiated on
the basis of clinical clues, the severity of the patient’s
illness, the underlying disease, and the potential pathogens.
All surgical procedures in the study population were for
internal jugular vein thrombosis. Surgical procedures were
performed under general anesthesia. The patient was
placed in the supine position and the head was slightly
extended and turned away from the side of the operation. A
vertical skin incision was made along the palpable anterior
border of the sternocleidomastoid muscle. After adequate
dissection, the internal jugular vein was exposed. The re-
gions that were proximal and distal to the thrombosed vein
appeared to be free of disease and vein cross clamping was
performed after systemic heparinization. A longitudinal
venotomy was made: it extended beyond the proximal and
distal end points of the thrombosed vein segment if
possible, and open thrombectomy was performed. Primary
closure was performed with optical 3.5  power magniﬁ-
cation and Prolene 6/0 continuous sutures. All patients
were anticoagulated and were followed up both clinically
and by DUS or CT scanning. Anticoagulant therapy was
delivered as a regimen of low molecular weight heparin at a
therapeutic dose, except in six patients who received con-
ventional heparin because of poor renal function.
The risk factors of interest and other data, including clinical
presentation, management details, and clinical outcomes,
were recorded prospectively in an Excel spreadsheet
(Microsoft, Redmond, WA, USA) and were analyzed retro-
spectively. Categorical data are reported as counts and per-
centages, while continuous data are reported asmeans SD.
RESULTS
Patient population
Between January 2009 and December 2012, 50 consecutive
patients were suspected of having central venous catheter
related infected thrombosis. However, four patients failed
the eligibility criteria because they had other causes of fever
or sepsis (Fig. 1). All were excluded, leaving 46 patients. All
patients received conservative management. The de-
mographics and clinical characteristics of these patients are
Figure 1. Flow chart of patient inclusion. DVT ¼ deep venous thrombosis. 1In hospital mortality without surgical thrombectomy.
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shown in Table 1. The most common underlying disease was
malignancy (n¼ 23; 50.0%), and 24 (52.2%) patients were in
an intensive care unit at the onset of the syndrome. The
reasons for central venous catheter placement, the diag-
nostic modality used to detect thrombosis, and the location
of thrombus are summarized in Table 1. The mean duration
of central venous catheterization was 23.7  19.2 days, and
the mean duration from the placement of the central venous
catheter to the diagnosis of catheter related thrombosis was
25.5  15.4 days. The mean length of stay in an intensive
care unit was 35.6  45.6 days, and the average overall
length of hospital stay was 62.0  46.0 days.
Conservative management
All patients received antimicrobial therapy after sepsis was
suspected. They were all also anticoagulated after the diag-
nosis of catheter related thrombosis. The blood and catheter
cultures were positive in 31 (67.4%) and 25 (54.3%) patients,
respectively. The most common pathogens were Staphylo-
coccus aureus (n ¼ 15; 32.6%) and Candida species (n ¼ 8;
17.4%). Conservative management led to clinical improve-
ment in 26 (56.5%) patients, but failed in 20 (43.5%).Thirteen
(28.3%) of the patients who failed conservative management
underwent surgical thrombectomy. The remaining seven did
not: four (8.7%) died in hospital and three (6.5%) could not
undergo surgery because of an unacceptable general con-
dition. Thus, in total, 33 patients received conservative
management without surgical thrombectomy. Of these,
eight (24.2%) died in hospital and two (8.0%) died during the
follow up period (59.0  3.4 months) (Table 2).
Surgical thrombectomy
Thirteen (28.3%) patients were refractory to conservative
management and underwent surgical thrombectomy. The
intra-operative ﬁndings in most cases revealed intense
perivascular inﬂammation that enveloped the vein con-
taining the thrombus. The thrombus material was thick,
organized, and densely adherent to the vein wall (Fig. 2).
The thrombus was removed completely in six of the 13
(46.2%) patients. In the remaining seven (53.8%) patients,
small remnants of the partially organized clots remained at
the proximal vein wall. There were no post-operative
complications that related to the surgical procedure,
except for one (7.7%) wound hematoma. The patency of the
involved vein was re-established in 12 (92.3%) patients.
Table 1. Patient demographics and clinical characteristics.
Variable Number
of patients
(n ¼ 46)
Mean age (years) 67.1  13.6
Male sex 26 (56.5)
Hypertension 19 (41.3)
Diabetes mellitus 9 (19.6)
Underlying disease
Malignancy 23 (50.0)
Bowel ischemia 5 (10.9)
Multiple trauma 5 (10.9)
End stage renal disease 5 (10.9)
Others 8 (17.3)
Intensive care unita 24 (52.2)
Ventilator carea 21 (45.7)
Reason for central venous catheter placement
Hemodynamic monitoring 19 (41.3)
Hemodialysis 11 (23.9)
Total parenteral nutrition 9 (19.6)
Drug therapy 7 (15.2)
Duration of central venous catheter use (days) 23.7  19.2
Diagnostic modality to detect thrombosis
DUS 21 (45.7)
CT scan 14 (30.4)
DUS þ CT scan 11 (23.9)
Location of thrombosis
Internal jugular vein 39 (84.8)
Subclavian vein 6 (13.0)
Superior vena cava 1 (2.2)
Length of intensive care
unit stay (days)
35.6  45.6
Length of hospital stay (days) 62.0  46.0
Note. Continuous data are shown as mean  SD; categorical data
are shown as n (%). DUS ¼ Duplex ultrasonography;
CT ¼ computed tomographic.
a Intensive care unit and ventilator care at the onset of syndrome.
Table 2. Clinical features and outcomes.
Variable Conservative
management
(n ¼ 33)
Surgical
thrombectomy
(n ¼ 13)
Blood culture positivity 21 (63.7) 10 (77.0)
Catheter culture
positivity
18 (54.5) 7 (53.8)
Tissue culture positivity d 3 (23.1)
Pathogens
Coagulase negative
Staphylococci
2 (6.1) 1 (7.7)
Staphylococcus
aureus
11 (33.3) 4 (30.8)
Aerobic Gram
negative
bacilli
5 (15.2) 0 (0.0)
Candida albicans 3 (9.1) 4 (30.8)
Candida non-albicans 0 (0.0) 1 (7.7)
Patency ratea 14 (42.4) 12 (92.3)
Clinical improvement 26 (78.8) 11 (84.6)
In hospital mortality 8 (24.2) 3 (23.1)
Multiorgan failure 5 (62.5) 0 (0.0)
Septic shock 1 (12.5) 2 (66.7)
ARDS 2 (25.0) 0 (0.0)
ICH 0 (0.0) 1 (33.3)
Mortalityb 2 (8.3) 3 (30.0)
Multiorgan failure 1 (50.0) 0 (0.0)
Septic shock 0 (0.0) 1 (33.3)
Pneumonia 0 (0.0) 1 (33.3)
Cancer progression 1 (50.0) 0 (0.0)
Unknown 0 (0.0) 1 (33.3)
Note. Categorical data are given as n (%). ARDS ¼ acute respiratory
distress syndrome; ICH ¼ intracranial hemorrhage.
a Partial or complete resolution of thrombosis during the follow up
period.
b Mortality among survivors during the follow up period.
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Although only three of the 13 (23.1%) patients who un-
derwent surgery had a positive tissue culture, clinical
improvement was achieved in 11 (84.6%). Moreover the
pyrexia of the ﬁve patients whose blood cultures were
positive for Candida species promptly returned to normal
after surgical thrombectomy. Of the 13 patients treated
surgically, there were three (23.1%) in hospital deaths, and
three of the 10 (30.0%) survivors died during the follow up
period (43.0  8.1 months) (Table 2).
DISCUSSION
Central venous catheters are subject to thrombosis and
infection. The frequency of these complications depends on
the duration of catheterization and various host factors.5e11
The risk of infection varies with a number of factors, such as
the type of device, the insertion site, and adherence to
preventive measures.7e9 It also appears that the risk of
infection is not linear with the duration of catheterization
but increases over time.8 In addition, central venous cath-
eter related infected thrombosis is known to increase the
length of hospital stay, as well as hospital costs.7e9
Although the vast majority of catheter related thromboses
are occult and may not present clinically, it can be a serious
infectious complication that leads to signiﬁcant morbidity
and, if left untreated, death.1e12 Furthermore, as the
pathogenesis of catheter related infections is complicated,
the virulence of the pathogens is variable, and the host
factors have not been well deﬁned. Thus, there is a notable
lack of compelling clinical data that helps the care team
make a ﬁrm recommendation for an individual patient.7
Long-term catheters may develop a ﬁbrin sheath or tail at
the distal catheter tip. Moreover, the daily infusion of hy-
pertonic parenteral solutions may cause central venous
thrombosis. Clots near to or on the catheter surface are prime
sites for microbial seeding and eventual infection.6 Patients
receiving long-term parenteral nutrition may also have se-
vere trauma and critical illnesses and/or have to undergo
major surgery. All of these factors signiﬁcantly affect immune
function and increase the risk of developing infection.6 In
addition to focal thrombophlebitis, the infection can spread
to other visceral organs, resulting in pneumonia, infective
endocarditis, or metastatic seeding.3,7e9 Staphylococcus
aureus, coagulase-negative Staphylococci, and Candida spe-
cies are the most common causes of catheter related
bloodstream infection.7e9 Central venous catheter related
infected thrombosis can cause lethal complications such as
persistent bacteremia, shock, and metastatic infection.3
The diagnosis of septic thrombosis in immobilized and
critically ill patients is difﬁcult to establish by clinical exami-
nation, although extremity or facial edema that corresponds
to the involved vein may develop.1 However, the known risk
factors for the development of the disease are total paren-
teral nutrition via a central venous catheter, prior surgery or
trauma, multiple previous antibiotic therapies, prolonged
venous catheterization, and many conditions that result in
immunosuppression. Whenever a patient has any of these
risk factors for catheter related infected thrombosis, there
must be a very high level of suspicion.3,5 While ultrasono-
graphic evaluation can help to detect the venous thrombosis,
CT scanning is also of great beneﬁt as it can also reveal the
extent of the thrombosis and the presence of peri-venous
ﬂuid, soft tissue abscesses, or additional organ involvement.1
In cases of suspected central venous catheter related
infected thrombosis, treatment includes the prompt removal
or change of the catheter, antibiotic therapy, anticoagulation
therapy, and cultures of the blood and the tip of the catheter.
However, anticoagulation is not mandatory for successful
treatment,1 and further study is needed to determine
whether this therapy actually does prevent further throm-
bosis in the setting of catheter related infection. Neverthe-
less, in the absence of contraindications, it is recommended
that anticoagulation be part of the conservative manage-
ment of this disease. The good overall outcomes of this kind
of management (especially when it is performed with mod-
ern, more effective antibiotic drugs) is the main reason why
many authors regard antibiotic and anticoagulation therapy
as an adequate treatment strategy for septic thrombophle-
bitis after intravenous catheter placement.1 However, the
substantial complication rate associated with this strategy
has led several authors to recommend a surgical approach if
the sepsis is refractory to this conservative treatment.1,10
The surgical management of septic thrombophlebitis
consists of various treatment modalities.1 Surgical throm-
bectomy can safely remove the source of embolization and
the patency of the vein is re-established in many cases.1 In
addition, surgical thrombectomy may enhance the effec-
tiveness of antibiotic therapy because it removes most of
the infected material, leaving the infected vein wall in close
contact with the antibiotic.1 In most cases, the thrombus
material is old and smaller remnants of the partially orga-
nized clots can remain on the vein wall.1 Recent reports
show that endovascular treatment may also be a useful
addition in the management of catheter related infected
thrombosis.13e18 However, one report shows that throm-
bolysis alone or in conjunction with mechanical thrombec-
tomy can trigger signiﬁcant deterioration, presumably
because it releases infected emboli into the systemic cir-
culation.13 Future studies with larger cohorts that examine
Figure 2. Intra-operative ﬁndings show that the thrombus material
(white arrows) in this case of catheter related septic thrombosis
was thick, organized, and densely adherent to the vein wall.
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the risks and beneﬁts of endovascular treatment in catheter
related septic thrombosis are warranted.
In the present study, 13 (28.3%) patients were refractory
to conservative management but had a sufﬁciently good
clinical condition to undergo surgical thrombectomy. After
surgical thrombectomy, clinical improvement was achieved
in 11 (84.6%). In particular, all ﬁve patients whose blood
culture was positive for Candida species promptly defer-
vesced after surgical thrombectomy. It has been well docu-
mented that fungemia is associated with total parenteral
nutrition, antibiotic use, prolonged venous catheterization,
and many conditions resulting in immunosuppression.3,5
Unlike bacterial thrombophlebitis, fungal thrombophlebitis
is unimpressive in its appearance and thus is often not
discovered until it is speciﬁcally investigated. Unfortunately,
this usually only occurs after fungemia, shock, or organ fail-
ure is recognized.19,20 Surgical patients, especially those with
intra-abdominal infection, who are critically ill while being
treated with long-term antimicrobial therapy should be
suspected of fungal infection.3 The catheter should be
removed in cases of central venous catheter related septic
thrombosis due to Candida species.7 Echinocandins are the
preferred treatment in catheter related fungemia. For pa-
tients who cannot tolerate echinocandins, lipid formulations
of amphotericin B are an alternative. Fluconazole can be
considered if patients are not critically ill and if they have not
had recent exposure to azoles.7e9 Treatment for 14 days
after the ﬁrst negative blood culture is sufﬁcient in uncom-
plicated fungemia without persistent fungemia or metastatic
complications.7e9
Several limitations should be noted. This study has a
retrospective design and the decision of whether or not and
when to perform a surgical thrombectomy was made by the
surgeon, based on the expected level of the efﬁcacy of
conservative management and the patient’s general con-
dition. Furthermore, the number of patients that under-
went surgical thrombectomy was relatively small. Hence, in
the patients who received surgical treatment, clinical
improvement in some of these patients may only have
represented the natural course of the disease. Future
studies on larger cohorts are warranted.
The small sample size in the present study means that
the importance of surgical thrombectomy in the treatment
of central venous catheter related infected thrombosis
cannot yet be deﬁnitively determined. Without doubt,
conservative management is the ﬁrst therapy of choice.
However, the authors believe that surgical thrombectomy
can be beneﬁcial and life saving in selected patients who
fail conservative management. This approach may be
controversial, but it should be emphasized that it does not
compete with conservative management: rather, it is a
supplemental treatment modality whose application de-
pends on the severity of the disease and its efﬁcacy relative
to conservative management.
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Give it a Twist!
Y. Georg, N. Chakfé *
Department of Vascular Surgery and Kidney Transplantation, Les Hôpitaux Universitaires de Strasbourg, and University of Strasbourg, Strasbourg, France
A 75 year old man was treated for a 5.5 cm diameter abdominal aortic aneurysm involving both common iliac arteries, using a C3
Excluder and iliac branch (IBE) devices (WL Gore, Flagstaff, AZ, USA) on both sides, to preserve his pelvic perfusion. The procedure took
240 minutes and was uneventful except for the accidental anterior opening of the left IBE device, which did not prevent hypogastric
artery cannulation. The post-operative CT control demonstrated this amazing picture with a complete winding of the iliac limbs. After 6
months the aneurysm was completely excluded and the branches remained patent without kinks or disconnection.
* Corresponding author. Department of Vascular Surgery, Les Hôpitaux Universitaires de Strasbourg, B.P. 426, 67091 Strasbourg Cedex, France.
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